Regencell Bioscience (NASDAQ:RGC) Shares Gap Down – Here’s What Happened

Regencell Bioscience Holdings Limited (NASDAQ:RGC) shares gapped down before the market opened on Monday . The stock had previously closed at $21.16, but opened at $20.00. Regencell Bioscience shares last traded at $23.18, with a volume of 146,804 shares trading hands.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Regencell Bioscience in a report on Monday, December 22nd. One analyst has rated the stock with a Sell rating, According to MarketBeat, the stock currently has an average rating of “Sell”.

Regencell Bioscience Stock Up 12.8%

The company’s 50 day simple moving average is $15.57.

Institutional Investors Weigh In On Regencell Bioscience

Several hedge funds have recently modified their holdings of RGC. Geode Capital Management LLC increased its holdings in Regencell Bioscience by 5,637.5% during the second quarter. Geode Capital Management LLC now owns 391,066 shares of the company’s stock valued at $6,664,000 after buying an additional 384,250 shares during the period. Squarepoint Ops LLC bought a new stake in Regencell Bioscience during the 2nd quarter valued at $1,701,000. BNP Paribas Financial Markets purchased a new position in shares of Regencell Bioscience in the 2nd quarter valued at $768,000. XTX Topco Ltd bought a new position in shares of Regencell Bioscience in the 3rd quarter worth $598,000. Finally, Y Intercept Hong Kong Ltd purchased a new stake in shares of Regencell Bioscience during the 2nd quarter worth $222,000. Hedge funds and other institutional investors own 0.13% of the company’s stock.

About Regencell Bioscience

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.